Urine biopsy offers a more accurate way to detect bladder, kidney and prostate cancers
A 2026 study in Singapore reveals that urine liquid biopsy is a highly effective, non-invasive method for detecting bladder, kidney, and prostate cancers. By analyzing genetic fragments like DNA and RNA in urine, this method offers higher accuracy than traditional cytology.
Why it matters
This technology could revolutionize cancer screening by providing a painless, more accurate alternative to invasive biopsies and traditional diagnostic methods.
Using an emerging urine test on a sample like this can detect bladder, kidney and prostate cancers more accurately, a study found. SINGAPORE – An emerging urine test has proved to be more accurate than conventional methods in detecting bladder and prostate cancers, while providing patients with a less painful and invasive screening option for prostate and kidney cancers.
The article reports on scientific study findings without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in